A multicenter, single-arm phase II trial of bevacizumab beyond initial progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in Advanced Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 15 Jan 2014 Status changed from active, no longer recruiting to completed as reported by Hospital Medical Information Network - Japan record.
- 03 Dec 2012 Planned end date changed from 1 Jul 2012 to 6 May 2012 as reported by University Hospital Medical Information Network - Japan.
- 05 Dec 2011 New trial record